Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 28;4(1):43-48.
doi: 10.1016/j.xfre.2023.01.006. eCollection 2023 Mar.

At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably with serum estradiol

Affiliations

At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably with serum estradiol

Gary S Nakhuda et al. F S Rep. .

Abstract

Objective: To investigate the feasibility of monitoring urine estrone-3-glucuronide (E3G) with an at-home device during gonadotropin stimulation for in vitro fertilization and oocyte cryopreservation.

Design: Prospective, observational cohort study.

Setting: Private fertility clinic.

Patients: Thirty patients undergoing stimulation with a gonadotropin-releasing hormone antagonist protocol for in vitro fertilization or oocyte cryopreservation.

Interventions: Daily collection of the first urine in the morning during stimulation and analysis performed at home by each patient with the Mira Fertility Tracker.

Main outcome measures: Primary outcomes were correlation of urine E3G and serum estradiol (E2) concentrations on the day of trigger to the number of total and metaphase 2 oocytes (MII). Secondary outcomes of interest were the correlation of matched E3G and E2 measurements and the daily trends of E3G and E2 during stimulation.

Results: Both urine E3G and serum E2 concentrations on the day of trigger significantly correlated with retrieval outcomes to a similar extent, with E3G demonstrating slightly higher correlation to the number of MII oocytes than that demonstrated by E2 (r = 0.485 vs. 0.391, respectively). The Pearson correlation coefficient for matched E3G and E2 levels was 0.761. The correlation coefficients of determination for daily trends of E3G and E2 during stimulation were 0.7066 and 0.6102, respectively.

Conclusions: Measured on the day of trigger, urine E3G monitoring during gonadotropin stimulation was comparable with serum E2 for predicting oocyte retrieval outcomes. Matched daily samples confirmed good correlation of urine E3G and serum E2. The option of at-home estrogen monitoring with devices such as Mira offers an alternative to traditional serum monitoring that may improve patient experience.

Clinical trial registration number: NCT05493202.

Keywords: Home urine test; IVF; estrone-3-glucuronide; immunoassay; telehealth.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Matched urine estrone-3-glucuronide (E3G) and serum estradiol (E2).
Figure 2
Figure 2
Box plot of daily serum estradiol (E2) and urine estrone-3-glucuronide (E3G) over the stimulation course.

Similar articles

Cited by

References

    1. Drakopoulos P., Blockeel C., Stoop D., Camus M., de Vos M., Tournaye H., et al. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31:370–376. - PubMed
    1. Garnett E., Bruno-Gaston J., Cao J., Zarutskie P., Devaraj S. The importance of estradiol measurement in patients undergoing in vitro fertilization. Clin Chim Acta. 2020;501:60–65. - PubMed
    1. Genuis S.J., Bouchard T.P. High-tech family planning: reproductive regulation through computerized fertility monitoring. Eur J Obstet Gynecol Reprod Biol. 2010;153:124–130. - PubMed
    1. Usala S.J., Alliende M.E., Trindade A.A. Algorithms with area under the curve for daily urinary estrone-3-glucuronide and pregnanediol-3-glucuronide to signal the transition to the luteal phase. Medicina (Kaunas) 2022;58:119. - PMC - PubMed
    1. Behre H.M., Kuhlage J., Gassner C., Sonntag B., Schem C., Schneider H.P., et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod. 2000;15:2478–2482. - PubMed

Associated data